Details for New Drug Application (NDA): 021528
✉ Email this page to a colleague
The generic ingredient in ACULAR LS is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.
Summary for 021528
| Tradename: | ACULAR LS |
| Applicant: | Abbvie |
| Ingredient: | ketorolac tromethamine |
| Patents: | 1 |
Pharmacology for NDA: 021528
| Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 021528
Suppliers and Packaging for NDA: 021528
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ACULAR LS | ketorolac tromethamine | SOLUTION/DROPS;OPHTHALMIC | 021528 | NDA | Allergan, Inc. | 0023-9277 | 0023-9277-05 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9277-05) / 5 mL in 1 BOTTLE, DROPPER |
| ACULAR LS | ketorolac tromethamine | SOLUTION/DROPS;OPHTHALMIC | 021528 | NDA AUTHORIZED GENERIC | A-S Medication Solutions | 50090-3550 | 50090-3550-0 | 1 BOTTLE, DROPPER in 1 CARTON (50090-3550-0) / 5 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.4% | ||||
| Approval Date: | May 30, 2003 | TE: | AT | RLD: | Yes | ||||
| Patent: | 8,008,338*PED | Patent Expiration: | Nov 24, 2027 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Expired US Patents for NDA 021528
Complete Access Available with Subscription
